Electra Therapeutics Inc. (ETRA) vs Ovid Therapeutics (OVID)

Electra Therapeutics Inc. ETRA 7.87 −2.48%
Ovid Therapeutics OVID 2.73 +13.75%

Electra Therapeutics Inc. and Ovid Therapeutics are both Biotechnology companies. Electra Therapeutics Inc. and Ovid Therapeutics are of similar size ($506.5M and $468.7M).

Metric	ETRA	OVID	Biotechnology median
P/E	—	n/m	10.64
P/S	—	60.33	9.59
P/B	—	2.26	2.15
Price to free cash flow	—	n/m	26.07
EV/EBITDA	—	n/m	0.65
EV/Sales	—	46.84	9.45
Earnings yield	—	(9.39%)	(34.69%)
Free cash flow yield	—	(11.59%)	(24.02%)

Metric	ETRA	OVID	Biotechnology median
Gross margin	—	100.00%	65.59%
Operating margin	—	(742.97%)	0.00%
Net margin	—	(439.11%)	0.00%
Free cash flow margin	—	(697.30%)	0.00%
Return on equity	—	(25.97%)	(51.96%)
Return on assets	—	(22.30%)	(46.06%)
Return on invested capital	—	(35.11%)	0.00%

Metric	ETRA	OVID	Biotechnology median
Revenue growth (TTM)	—	1,333.39%	4.59%
EPS growth (last fiscal year)	—	37.84%	29.88%
Revenue growth, 5-year CAGR	—	(10.48%)	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ETRA	OVID	Biotechnology median
Debt to equity	—	0.05	0.00
Current ratio	—	12.39	4.86
Net debt to EBITDA	—	1.37	1.01

Metric	ETRA	OVID	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	ETRA	OVID	Biotechnology median
Market cap	506.53m	468.71m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack